NISA INVESTMENT ADVISORS, LLC
Position in CLOV — Clover Health Investments, Corp. /De
CIK 937615
ST. LOUIS, MO
Position in CLOV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$17,590
+$9,882 QoQ
Shares Held
3,357
-23.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#180
of 224 holders
Holding Since
Sep 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLOV Over Time
Shares Held
Position Value (USD)
Position in Healthcare Plans
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $225,124,193 across 11 Healthcare Plans names. CLOV ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UNH |
Unitedhealth Group Inc
|
251,966 | $104,724,628 | |
| 2 | CVS |
CVS HEALTH Corp
|
343,555 | $35,540,764 | |
| 3 | ELV |
Elevance Health, Inc.
|
75,113 | $29,048,450 | |
| 4 | CI |
Cigna Group
|
101,541 | $27,992,822 | |
| 5 | CNC |
Centene Corp
|
221,143 | $14,195,169 | |
| 6 | HUM |
Humana Inc
|
24,645 | $9,789,486 | |
| 7 | MOH |
Molina Healthcare, Inc.
|
14,541 | $3,325,526 | |
| 8 | OSCR |
Oscar Health, Inc.
|
8,236 | $234,890 |
All Filings in CLOV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,590 | 3,357 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $7,708 | 4,380 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $10,191 | 4,337 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $12,582 | 4,112 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $10,568 | 3,788 | Shares | Sole | 2025-07-31 | |
| 2023-12-31 | $52 | 55 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $59 | 55 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $49 | 55 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $211 | 250 | Shares | Sole | 2023-05-02 | |
| 2022-09-30 | $13,940 | 8,200 | Shares | Sole | 2022-11-07 | |
| No filing history on record for this holder in this stock. | ||||||